Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Journal of Forensic Sciences|October 5, 2006
Changing patterns of drug and alcohol use in fatally injured drivers in Washington StateEugene W Schwilke, Maria Isabel Sampaio dos Santos, Barry K LoganJournal of Chromatography. A|July 21, 2007
Simultaneous quantification of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol, and 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in human plasma using two-dimensional gas chromatography, cryofocusing, and electron impact-mass spectrometryRoss H Lowe, Erin L Karschner, Eugene W Schwilke, et al.Clinical Chemistry|September 17, 2005
Disposition of cocaine and its metabolites in human sweat after controlled cocaine administrationSherri L Kacinko, Allan J Barnes, Eugene W Schwilke, et al.Clinical Chemistry|June 3, 2006
Opioid disposition in human sweat after controlled oral codeine administrationEugene W Schwilke, Allan J Barnes, Sherri L Kacinko, et al.Drug and Alcohol Dependence|April 3, 2012
Predictive model accuracy in estimating last Δ9-tetrahydrocannabinol (THC) intake from plasma and whole blood cannabinoid concentrations in chronic, daily cannabis smokers administered subchronic oral THCErin L Karschner, David M Schwope, Eugene W Schwilke, et al.Clinical Chemistry|March 7, 2009
Intra- and intersubject whole blood/plasma cannabinoid ratios determined by 2-dimensional, electron impact GC-MS with cryofocusingEugene W Schwilke, Erin L Karschner, Ross H Lowe, et al.Clinical Chemistry|November 6, 2007
Excretion of methamphetamine and amphetamine in human sweat following controlled oral methamphetamine administrationAllan J Barnes, Michael L Smith, Sherri L Kacinko, et al.Journal of Analytical Toxicology|October 31, 2009
Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokersErin L Karschner, Eugene W Schwilke, Ross H Lowe, et al.Clinical Chemistry|August 31, 2011
Oral fluid and plasma cannabinoid ratios after around-the-clock controlled oral Δ(9)-tetrahydrocannabinol administrationGarry Milman, David M Schwope, Eugene W Schwilke, et al.Addiction (Abingdon, England)|October 7, 2009
Do Delta9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users?Erin L Karschner, Eugene W Schwilke, Ross H Lowe, et al.Pageof 2